Avania, a global medical technology contract research organization, completed the acquisition of Maxis, a medical technology development service provider. Financial terms were not disclosed. “This acquisition strengthens our position as the leading MedTech focused CRO, advancing innovative medical technologies from ideation to commercialization, providing a range of highly customizable services in combination with robust global regulatory, clinical, and operational strategies to meet the unique needs of emerging OEMs. The addition of MAXIS furthers our strategy and will provide us with enhanced capabilities across a broader customer base as we continue to innovate and grow,” Sapna Hornyak, Avania President and CEO.